X0306 4 2020-03-02 0 0001412408 Phreesia, Inc. PHR 0001777450 Davidoff Michael J. C/O PHREESIA, INC. 432 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 0 1 0 0 See Remarks Common Stock 2020-03-02 4 M 0 17066 4.71 A 101453 D Common Stock 2020-03-02 4 S 0 10115 29.3895 D 91338 D Common Stock 2020-03-02 4 S 0 6451 30.476 D 84887 D Common Stock 2020-03-02 4 S 0 500 30.952 D 84387 D Stock Option (Right to Buy) 4.71 2020-03-02 4 M 0 17066 0.00 D 2028-01-30 Common Stock 17066 17066 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.89 to $29.87 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.This option is fully vested and exercisable as of the date hereof. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $30.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.This option is fully vested and exercisable as of the date hereof. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.92 to $30.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.This option is fully vested and exercisable as of the date hereof. 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. SVP, Marketing and Business Development /s/ Charles Kallenbach by Power of Attorney for Michael Davidoff 2020-03-04